(2026). Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Elevated Autoantibodies Against Dipeptidyl Peptidase-4 Are Associated with Poor Prognosis in Patients with Type 2 Diabetes."
Endocrine Journal 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Elevated Autoantibodies Against Dipeptidyl Peptidase-4 Are Associated with Poor Prognosis in Patients with Type 2 Diabetes."
Endocrine Journal, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.